Thesis Abstract : Public Health

โครงการร่วมคณะเภสัชศาสตร์ คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี คณะแพทยศาสตร์ศิริราชพยาบาล คณะสาธารณสุขศาสตร์ คณะสังคมศาสตร์และมนุษยศาสตร์ และสถาบันวิจัยประชากรและสังคม

• COST-UTILITY AND BUDGET IMPACT ANALYSIS OF ADDING SGLT-2 INHIBITOR TO STANDARD TREATMENT FOR TYPE 2 DIABETES WITH HEART FAILURE IN THAILAND [ 2566 ]

  AUTHOR: TANAWAN KONGMALAI

  ADVISOR: Associate Professor VARALAK SRINONPRASERT

• CAPACITY FOR HEALTH TECHNOLOGY ASSESSMENT AND COST-EFFECTIVENESS THRESHOLD DEVELOPMENT FOR POLICY DECISION-MAKING IN THE PHILIPPINES [ 2564 ]

  AUTHOR: MAC ARDY JUNIO GLORIA

  ADVISOR: Associate Professor DR. MONTARAT THAVORNCHAROENSAP

• COST UTILITY ANALYSIS OF LAPAROSCOPIC BARIATRIC SURGERY FOR OBESITY WITH TYPE II DIABETES MELLITUS [ 2563 ]

  AUTHOR: PRAPAPORN NOPARATAYAPORN

  ADVISOR: Associate ProfessorDR. MONTARAT THAVORNCHAROENSAP

• COST UTILITY ANALYSIS OF ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS: A SYSTEMATIC REVIEW AND META ANALYSIS [ 2563 ]

  AUTHOR: RINI NOVIYANI

  ADVISOR: Professor DR. AMMARIN THAKKINSTIAN

• COST-EFFECTIVENESS OF APPLYING HOME BLOOD PRESSURE MEASUREMENT AND CLINIC BLOOD PRESSURE MEASUREMENT FOR SINGLE OR SERIAL SCREENING AND DIAGNOSIS OF HYPERTENSION [ 2562 ]

  AUTHOR: AUTTAKIAT KARNJANAPIBOONWONG

  ADVISOR: Assistant Professor Dr. THUNYARAT ANOTHAISINTAWEE

• COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 1 AND 6 IN VIETNAM [ 2561 ]

  AUTHOR: ONG THE DUE

  ADVISOR: Associate Professor Dr. Usa Chaikledkaew